Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Dyne Therapeutics, Inc
About DYN
Dyne Therapeutics, Inc. is a clinical-stage neuromuscular disease company. It is discovering and advancing therapeutics for people living with genetically driven neuromuscular diseases. Leveraging the modularity of its FORCE platform, it is developing targeted therapeutics that deliver to muscle and central nervous system (CNS). It has a broad pipeline for neuromuscular diseases, including clinical programs for myotonic dystrophy type 1 and Duchenne muscular dystrophy and preclinical programs for facioscapulohumeral muscular dystrophy and Pompe disease. Its product candidate, zeleciment basivarsen (also known as DYNE-101), is being evaluated in ACHIEVE, an ongoing Phase I/II global clinical trial in patients with DM1. Its product candidate, zeleciment rostudirsen (also known as DYNE-251), is being evaluated in DELIVER, an ongoing Phase I/II global clinical trial in patients with DMD who have mutations amenable to skipping exon 51. Its other product candidates are DYNE-302 and DYNE-401.
Find out what a historical investment in Dyne Therapeutics, Inc would be worth today using our DYN stock calculator.
Market Capitalisation
$2.63B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
1.93M
High today
$17.64
Low today
$16.06
Open price
$16.18
52-week high
$25.00
52-week low
$8.06
Ready to start your investing journey with Stake?
Open an accountHow do I buy DYN shares in Australia?
Buying DYN shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Dyne Therapeutics, Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in DYN
What is the ticker symbol of Dyne Therapeutics, Inc?
The ticker symbol for Dyne Therapeutics, Inc is DYN.
How much is one share of DYN?
One share of DYN is valued at $17.47 as of 20 May 2026.
What is the market capitalisation of Dyne Therapeutics, Inc DYN?
As of 20 May 2026 Dyne Therapeutics, Inc has a market cap of $2.63B.
What is the 52-week high for Dyne Therapeutics, Inc stock?
The Dyne Therapeutics, Inc 52-week high stock price is $25.00.
What is the 52-week low for Dyne Therapeutics, Inc stock?
The Dyne Therapeutics, Inc 52-week low stock price is $8.06.
Can I buy DYN shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy DYN shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in DYN on Stake
- Buy DYN from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of DYN from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
DYN related stocks